C-reactive protein is an independent predictor of mortality in women with HIV-1 infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 32, Issue 2, 2003, Pages 210-214

  Feldman, Joseph G ^a   Goldwasser, Philip ^b   Holman, Susan ^a   DeHovitz, Jack ^a   Minkoff, Howard ^a,c  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

C reactive protein; HIV 1 infection; Survival

Indexed keywords

C REACTIVE PROTEIN; CD4 ANTIGEN; SERUM ALBUMIN;

ADULT; AGE; ARTICLE; BODY MASS; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION ANALYSIS; COVARIANCE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MEASUREMENT; MEDICAL ASSESSMENT; MORTALITY; PREDICTION; PRIORITY JOURNAL; RNA VIRUS;

EID: 0037323008     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200302010-00014     Document Type: Article

References (15)

1. Fauci AS. The human immunodeficiency virus: infectivity and mechanism of pathogenesis. Science 1988;238:617-22.
2. Feldman JG, Burns DN, Gange SJ, et al. Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV Study. AIDS 2000;14:863-70.
3. Rifai N, Buring JE, I-Min L, et al. Is C-reactive protein specific for vascular disease in women? Ann Intern Med 2002;136:529-33.
4. Harris TB, Ferrucci L, Tracey RP, et al. Associations of elevated interlukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-12.
5. Melchior JC, Niyongabo T, Henzel D, et al. Malnutrition and wasting immunodepression, and chronic inflammation as independent predictors of survival in HIV infected patients. Nutrition 1999;15:865-9.
6. Barken SE, Melnick SL, Preston-Martin S, et al. The women's interagency study (WIHS)-design, methods, cohort characteristics and comparison with reported AIDS cases in U.S. women. Epidemiology 1998;9:117-25.
7. Gaby C, Kushner I. Acute phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
8. Gitlin JD, Colten HR. Molecular biology of acute phase plasma proteins. In Pick E, Landy M. Lymphokines, vol 14. San Diego: Academic Press, 1987:123-53.
9. Munford RS. Statins and acute phase response. N Engl J Med 2001;344:2016-8.
10. Tchernof A, Nolan A, Sites Ck, et al. Weight loss reduces C- reactive protein levels in obese postmenopausal women. Circulation 2002;105:564-9.
11. Ridker PM, Rifai N, Clearfield M, et al. Measurement of C- reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344: 1959-65.
12. Danesh J, Whincup P, Walker M, et al. Low grade inflammation and cornary disease: prospective study and updated meta analyses. BMJ 2000;321:199-204.
13. Rifai N, Ridker PM. C-reactive protein: a new strong predictor of cardiovascular disease. Clinical Laboratory News Oct. 2001;12-4.
14. Rafai N, Tracy RP, Ridker PM. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 1999;45: 2136-41.
15. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.